Compare CYRX & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYRX | TALK |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | 1100 | 521 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 788.5M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | TALK |
|---|---|---|
| Price | $8.22 | $5.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $12.94 | $6.42 |
| AVG Volume (30 Days) | 425.4K | ★ 7.0M |
| Earning Date | 03-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $10.92 | $26.02 |
| Revenue Next Year | $8.08 | $21.24 |
| P/E Ratio | ★ $5.86 | $155.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $2.22 |
| 52 Week High | $11.45 | $5.19 |
| Indicator | CYRX | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 66.60 |
| Support Level | $7.95 | $4.59 |
| Resistance Level | $8.52 | $5.19 |
| Average True Range (ATR) | 0.39 | 0.02 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 56.85 | 55.56 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.